Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine.

Published in: Genome medicine (2020)

Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of precision medicine in gastrointestinal disorders.

Keyphrases

irritable bowel syndrome
cell therapy
electronic health record
big data
stem cells
randomized controlled trial
systematic review
machine learning
mesenchymal stem cells
artificial intelligence
meta analyses